Cyclosporin and Raynaud phenomenon

Effect of <i>Opuntia dejecta</i> (Salm-Dyck) flowers in liver of fructose-fed rats: Biochemicals, enzymatic and histological studies.

Human & experimental toxicology·2021

Anticoagulants in frail patients. Seven situations at risk.

Journal de medecine vasculaire·2018

[Bilateral uveitis associated with nivolumab therapy].

Journal francais d'ophtalmologie·2018

Renal function and venous thromboembolic diseases.

Journal des maladies vasculaires·2016

[Comparison of early management of central retinal vein occlusion with ranibizumab versus hemodilution].

Journal francais d'ophtalmologie·2015

Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients.

Journal of autoimmunity·2015

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Revealing Griffithsin recognition of diverse virus-associated <i>N</i>-glycans using atomistic simulations: glycan compositions and branching patterns as key molecular determinants.

Physical chemistry chemical physics : PCCP·2026

Metabolite glues as a means of purine sensing and chemotherapeutic response.

Nature·2026

Induced ubiquitination of the partially disordered estrogen receptor alpha via a 14-3-3 directed molecular glue-PROTAC.

Nature communications·2026

Multifunctional polysaccharides for skin health: A review in antioxidant, anti-inflammatory, and regenerative mechanisms.

International journal of biological macromolecules·2026

Recent advances in the formulation and delivery applications of chitosan/Fucoidan nanoparticles.

International journal of biological macromolecules·2026

Impact of antigen and carrier substitution on the molecular weight and immunogenicity of the Pfs230D1-CRM197 malaria transmission-blocking vaccine.

Vaccine·2026

Related Experiment Videos

Cyclosporin and Raynaud phenomenon

Related Concept Videos

Effect of <i>Opuntia dejecta</i> (Salm-Dyck) flowers in liver of fructose-fed rats: Biochemicals, enzymatic and histological studies.

Anticoagulants in frail patients. Seven situations at risk.

[Bilateral uveitis associated with nivolumab therapy].

Renal function and venous thromboembolic diseases.

[Comparison of early management of central retinal vein occlusion with ranibizumab versus hemodilution].

Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Revealing Griffithsin recognition of diverse virus-associated <i>N</i>-glycans using atomistic simulations: glycan compositions and branching patterns as key molecular determinants.

Metabolite glues as a means of purine sensing and chemotherapeutic response.

Induced ubiquitination of the partially disordered estrogen receptor alpha via a 14-3-3 directed molecular glue-PROTAC.

Multifunctional polysaccharides for skin health: A review in antioxidant, anti-inflammatory, and regenerative mechanisms.

Recent advances in the formulation and delivery applications of chitosan/Fucoidan nanoparticles.

Impact of antigen and carrier substitution on the molecular weight and immunogenicity of the Pfs230D1-CRM197 malaria transmission-blocking vaccine.

Related Experiment Videos

Cyclosporin and Raynaud phenomenon

Related Concept Videos

Related Articles